View Post

Less Diarrhea Seen When Neratinib Given in Dose-Escalated Fashion for Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Christina Bennett, MS From: Administering neratinib in a dose-escalated fashion with optional loperamide was found to reduce the incidence of severe diarrhea in patients with HER2-positive, early-stage breast cancer, according to data from the phase 2 CONTROL trial reported at the 17th St. Gallen International Breast Cancer Conference 2021. The CONTROL trial ( Identifier: NCT02400476) enrolled 563 patients …

View Post

Cancer survivors plagued by lack of personal control

In In The News by Barbara Jacoby

By: Andrew M. Seaman From: After treatment for cancer, survivors often complain about a loss of personal control, a new study found. The study’s lead author said that while the responses can’t be generalized to all cancer survivors, people in the study often mentioned a physical problem or a wish to return to “normal.” “Cancer survivors are often caught …